NYSE : HIMS
Hims & Hers Health, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 29.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.92B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Hims & Hers Health, Inc. (HIMS) reported revenue of 2.58B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.58B | 2.35B | 1.48B | 872.00M | 526.92M | 271.88M |
| Cost of Revenue | 785.57M | 614.26M | 303.38M | 157.05M | 118.19M | 67.38M |
| Gross Profit | 1.79B | 1.73B | 1.17B | 714.95M | 408.72M | 204.49M |
| Selling, General & Admin | 1.71B | 1.46B | 1.03B | 693.16M | 445.86M | 289.05M |
| Research & Development | 183.38M | 149.30M | 78.82M | 48.23M | 29.24M | 22.38M |
| Operating Expenses | 1.89B | 1.61B | 1.11B | 741.39M | 475.10M | 311.43M |
| Operating Income | -97.37M | 121.16M | 65.88M | -26.44M | -66.38M | -106.94M |
| Interest Expense | -9.33M | -3.90M | ||||
| Interest & Investment Income | 27.53M | 23.53M | 10.35M | 9.03M | 2.61M | 390.00K |
| Other Non Operating Income (Expenses) | -26.78M | -5.75M | -541.00K | -1.15M | 378.00K | 3.86M |
| EBT Excluding Unusual Items | -105.95M | 135.03M | 75.69M | -18.55M | -63.39M | -102.69M |
| Gain (Loss) on Sale of Investments | -508.00K | 4.44M | ||||
| Asset Writedown | -1.15M | -1.13M | ||||
| Other Unusual Items | -15.54M | -15.54M | -3.98M | -3.02M | -1.19M | -8.11M |
| Pretax Income | -163.61M | 123.92M | 71.71M | -21.57M | -65.71M | -110.80M |
| Income Tax Expense | -21.58M | -4.44M | -54.33M | 1.98M | -31.00K | -3.14M |
| Net Income | -142.03M | 128.37M | 126.04M | -23.55M | -65.68M | -107.66M |
| Net Income to Common | -142.03M | 128.37M | 126.04M | -23.55M | -65.68M | -107.66M |
| Shares Outstanding (Basic) | 228.40M | 224.96M | 215.94M | 209.34M | 204.52M | 186.78M |
| Shares Outstanding (Diluted) | 228.40M | 258.23M | 236.81M | 209.34M | 204.52M | 186.78M |
| EPS (Basic) | -0.62 | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 |
| EPS (Diluted) | -0.62 | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 |
| Free Cash Flow | 83.03M | 73.96M | 209.43M | 56.26M | -29.25M | -35.24M |
| Free Cash Flow Per Share | 0.36 | 0.29 | 0.88 | 0.27 | -0.14 | -0.19 |
| Gross Margin | 69.53% | 73.83% | 79.45% | 81.99% | 77.57% | 75.22% |
| Operating Margin | -3.78% | 5.16% | 4.46% | -3.03% | -12.60% | -39.33% |
| Profit Margin | -5.51% | 5.47% | 8.54% | -2.70% | -12.46% | -39.60% |
| Free Cash Flow Margin | 3.22% | 3.15% | 14.18% | 6.45% | -5.55% | -12.96% |
| EBITDA | -10.18M | 175.66M | 82.97M | -16.92M | -58.90M | -102.86M |
| EBITDA Margin | -0.40% | 7.48% | 5.62% | -1.94% | -11.18% | -37.83% |
| D&A For EBITDA | 87.19M | 54.50M | 17.09M | 9.52M | 7.47M | 4.08M |
| EBIT | -97.37M | 121.16M | 65.88M | -26.44M | -66.38M | -106.94M |
| EBIT Margin | -3.78% | 5.16% | 4.46% | -3.03% | -12.60% | -39.33% |
| Advertising Expenses | 814.90M | 604.60M | 390.30M | 235.60M | 103.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 609.81M | 228.62M | 220.58M | 96.66M | 46.77M | 71.78M |
| Short-Term Investments | 231.24M | 348.88M | 79.67M | 124.32M | 132.85M | 175.49M |
| Cash & Short-Term Investments | 841.05M | 577.49M | 300.25M | 220.98M | 179.62M | 247.27M |
| Receivables | 375.29M | 32.15M | 6.08M | 6.75M | 3.23M | 3.58M |
| Inventory | 87.78M | 80.13M | 64.43M | 22.46M | 21.56M | 13.56M |
| Prepaid Expenses | 56.84M | 37.89M | 16.17M | 10.66M | 10.39M | 4.61M |
| Other Current Assets | 23.65M | 39.98M | 8.90M | 4.20M | 1.78M | 890.00K |
| Total Current Assets | 1.38B | 767.64M | 395.83M | 265.05M | 216.59M | 269.90M |
| Property, Plant & Equipment | 529.78M | 448.98M | 92.96M | 45.73M | 16.14M | 7.31M |
| Long-Term Investments | 31.20M | 351.26M | ||||
| Goodwill | 1.10B | 278.32M | 112.73M | 110.88M | 110.88M | 110.88M |
| Other Intangible Assets | 422.81M | 196.12M | 43.41M | 18.57M | 21.84M | 31.59M |
| Long-Term Deferred Tax Assets | 111.58M | 82.71M | 61.60M | |||
| Other Long-Term Assets | 47.11M | 29.68M | 1.00M | 947.00K | 889.00K | 898.00K |
| Total Assets | 3.63B | 2.15B | 707.54M | 441.19M | 366.34M | 420.58M |
| Accounts Payable | 501.30M | 143.28M | 91.18M | 43.07M | 32.36M | 19.64M |
| Accrued Expenses | 119.45M | 68.88M | 50.86M | 28.97M | 11.48M | 11.24M |
| Current Portion of Leases | 11.55M | 4.84M | 1.89M | 1.28M | 1.66M | 1.36M |
| Current Income Taxes Payable | 28.31M | 9.64M | 2.15M | 963.00K | 954.00K | |
| Current Unearned Revenue | 141.38M | 127.16M | 75.28M | 7.73M | 1.47M | 3.19M |
| Other Current Liabilities | 681.25M | 50.63M | 7.41M | 42.83M | ||
| Total Current Liabilities | 1.48B | 404.43M | 221.37M | 88.47M | 47.94M | 79.22M |
| Long-Term Debt | 1.37B | 972.58M | ||||
| Long-Term Leases | 169.39M | 143.17M | 9.46M | 8.67M | 3.65M | 4.12M |
| Long-Term Deferred Tax Liabilities | 30.93M | 28.86M | ||||
| Other Long-Term Liabilities | 255.89M | 64.74M | 22.00K | 3.01M | 2.63M | |
| Total Liabilities | 3.30B | 1.61B | 230.82M | 97.16M | 54.60M | 85.97M |
| Common Stock | 23.00K | 23.00K | 22.00K | 21.00K | 21.00K | 20.00K |
| Additional Paid-In Capital | 662.26M | 652.38M | 719.15M | 712.31M | 656.63M | 613.69M |
| Retained Earnings | -292.18M | -113.77M | -242.14M | -368.18M | -344.63M | -278.95M |
| Comprehensive Income & Other | -46.04M | 2.29M | -324.00K | -124.00K | -277.00K | -137.00K |
| Total Common Equity | 324.07M | 540.93M | 476.72M | 344.03M | 311.74M | 334.62M |
| Shareholders' Equity | 324.07M | 540.93M | 476.72M | 344.03M | 311.74M | 334.62M |
| Total Liabilities & Equity | 3.63B | 2.15B | 707.54M | 441.19M | 366.34M | 420.58M |
| Total Debt | 1.55B | 1.12B | 11.35M | 9.95M | 5.31M | 5.48M |
| Net Cash (Debt) | -705.19M | -543.10M | 288.91M | 211.03M | 174.32M | 241.79M |
| Net Cash Per Share | -3.09 | -2.10 | 1.22 | 1.01 | 0.85 | 1.29 |
| Filing Date Shares Outstanding | 233.31M | 227.94M | 222.17M | 214.25M | 208.46M | 205.07M |
| Total Common Shares Outstanding | 233.30M | 227.25M | 220.84M | 213.48M | 208.43M | 204.79M |
| Working Capital | -98.62M | 363.21M | 174.46M | 176.59M | 168.65M | 190.68M |
| Book Value Per Share | 1.39 | 2.38 | 2.16 | 1.61 | 1.50 | 1.63 |
| Tangible Book Value | -1.20B | 66.49M | 320.58M | 214.57M | 179.02M | 192.15M |
| Tangible Book Value Per Share | -5.15 | 0.29 | 1.45 | 1.01 | 0.86 | 0.94 |
| Machinery | 97.59M | 83.17M | 27.79M | 8.25M | 3.60M | |
| Leasehold Improvements | 30.73M | 15.93M | 10.93M | 2.26M | 155.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -142.03M | 128.37M | 126.04M | -23.55M | -65.68M | -107.66M |
| Depreciation & Amortization | 87.19M | 54.50M | 17.09M | 9.52M | 7.47M | 4.08M |
| Other Amortization | 7.14M | 4.53M | 144.00K | |||
| Asset Writedown & Restructuring Costs | 30.14M | 531.00K | 114.00K | 429.00K | 1.13M | |
| Loss (Gain) From Sale of Investments | -802.00K | -6.47M | -4.36M | -5.69M | 146.00K | 2.17M |
| Stock-Based Compensation | 153.64M | 135.24M | 92.32M | 66.08M | 42.82M | 67.21M |
| Other Operating Activities | 48.38M | 12.46M | -58.75M | 5.87M | 1.78M | -3.80M |
| Change in Inventory | 49.40M | -13.72M | -41.61M | -902.00K | -8.00M | -9.63M |
| Change in Accounts Payable | 348.95M | 30.30M | 43.71M | 7.32M | 12.72M | 9.85M |
| Change in Unearned Revenue | 31.43M | 51.60M | 67.55M | 6.26M | -1.72M | 1.41M |
| Change in Other Net Operating Assets | -21.65M | -97.34M | 8.97M | 8.14M | -17.20M | 1.82M |
| Operating Cash Flow | 263.45M | 300.01M | 251.08M | 73.48M | -26.53M | -34.41M |
| Capital Expenditures | -180.42M | -226.04M | -41.66M | -17.22M | -2.71M | -832.00K |
| Cash Acquisitions | -458.24M | -145.23M | -15.40M | -459.00K | -46.47M | |
| Sale (Purchase) of Intangibles | -21.39M | -16.55M | -11.10M | -9.27M | -4.53M | -4.17M |
| Investment in Securities | -241.93M | -637.14M | 49.10M | 14.39M | 42.41M | -104.79M |
| Investing Cash Flow | -901.98M | -1.02B | -19.05M | -12.11M | 34.70M | -156.27M |
| Long-Term Debt Issued | 970.00M | |||||
| Net Debt Issued (Repaid) | 390.43M | 970.00M | ||||
| Issuance of Common Stock | 24.88M | 17.47M | 30.89M | 4.62M | 3.42M | 275.92M |
| Repurchase of Common Stock | -206.48M | -206.63M | -135.54M | -16.09M | -3.90M | -28.02M |
| Other Financing Activities | -81.48M | -51.22M | -3.19M | -32.65M | -12.85M | |
| Financing Cash Flow | 127.34M | 729.62M | -107.84M | -11.47M | -33.13M | 235.04M |
| Foreign Exchange Rate Adjustments | -3.95M | 2.51M | -270.00K | -11.00K | -53.00K | -73.00K |
| Net Cash Flow | -515.14M | 7.18M | 123.92M | 49.89M | -25.01M | 44.29M |
| Free Cash Flow | 83.03M | 73.96M | 209.43M | 56.26M | -29.25M | -35.24M |
| Free Cash Flow Margin | 3.22% | 3.15% | 14.18% | 6.45% | -5.55% | -12.96% |
| Free Cash Flow Per Share | 0.36 | 0.29 | 0.88 | 0.27 | -0.14 | -0.19 |
| Levered Free Cash Flow | 849.44M | 110.51M | 178.62M | 66.38M | -44.35M | 52.46M |
| Unlevered Free Cash Flow | 848.13M | 108.42M | 178.62M | 66.38M | -44.35M | 52.32M |
| Cash Interest Paid | 1.74M | |||||
| Cash Income Tax Paid | 23.16M | 7.92M | 1.11M | 636.00K | 338.00K | |
| Change in Working Capital | 79.79M | -29.16M | 78.62M | 20.82M | -14.20M | 3.46M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.46B | 7.39B | 5.28B | 1.89B | 1.33B | 1.34B |
| Enterprise Value | 7.16B | 7.88B | 5.04B | 1.68B | 1.14B | 1.08B |
| Last Close Price | 27.68 | 32.47 | 24.18 | 8.90 | 6.41 | 6.55 |
| PE Ratio | 57.58 | 41.91 | ||||
| Forward PE | 80.26 | 55.10 | 47.31 | |||
| PS Ratio | 2.50 | 3.15 | 3.58 | 2.16 | 2.53 | 4.91 |
| PB Ratio | 19.93 | 13.66 | 11.08 | 5.48 | 4.27 | 3.99 |
| P/TBV Ratio | 111.18 | 16.48 | 8.79 | 7.44 | 6.95 | |
| P/FCF Ratio | 77.78 | 99.94 | 25.23 | 33.53 | ||
| P/OCF Ratio | 24.51 | 24.64 | 21.04 | 25.68 | ||
| PEG Ratio | 7.65 | |||||
| EV/Sales Ratio | 2.78 | 3.36 | 3.41 | 1.93 | 2.16 | 3.98 |
| EV/EBITDA Ratio | 44.86 | 60.75 | ||||
| EV/EBIT Ratio | 65.04 | 76.50 | ||||
| EV/FCF Ratio | 86.28 | 106.54 | 24.07 | 29.84 | ||
| Debt / Equity Ratio | 4.77 | 2.07 | 0.02 | 0.03 | 0.02 | 0.02 |
| Debt / EBITDA Ratio | 171.37 | 5.92 | 0.13 | |||
| Debt / FCF Ratio | 18.62 | 15.15 | 0.05 | 0.18 | ||
| Net Debt / Equity Ratio | 2.18 | 1.00 | -0.61 | -0.61 | -0.56 | -0.72 |
| Net Debt / EBITDA Ratio | -69.29 | 3.09 | -3.48 | 12.47 | 2.96 | 2.35 |
| Net Debt / FCF Ratio | 8.49 | 7.34 | -1.38 | -3.75 | 5.96 | 6.86 |
| Asset Turnover | 0.94 | 1.64 | 2.57 | 2.16 | 1.34 | 1.01 |
| Inventory Turnover | 6.84 | 8.50 | 6.98 | 7.13 | 6.73 | 7.88 |
| Quick Ratio | 0.82 | 1.51 | 1.38 | 2.57 | 3.81 | 3.17 |
| Current Ratio | 0.93 | 1.90 | 1.79 | 3.00 | 4.52 | 3.41 |
| Return on Equity (ROE) | -32.03% | 25.23% | 30.71% | -7.18% | -20.32% | -49.19% |
| Return on Assets (ROA) | -2.21% | 5.29% | 7.17% | -4.09% | -10.54% | -24.79% |
| Return on Capital Employed (ROCE) | -4.50% | 6.90% | 13.60% | -7.50% | -20.80% | -31.30% |
| Earnings Yield | -2.25% | 1.74% | 2.39% | -1.25% | -4.93% | -8.06% |
| FCF Yield | 1.29% | 1.00% | 3.96% | 2.98% | -2.20% | -2.64% |
| Buyback Yield / Dilution | 7.33% | -9.05% | -13.12% | -2.36% | -9.50% | -428.32% |